Retrospective Safety Analysis of Atomoxetine in Adult ADHD Patients with or without Comorbid Alcohol Abuse and Dependence

REFERENCES

• Riccio CA, Wolfe M, Davis B, Romine C, George C, Lee D. Attention deficit hyperactivity disorder: manifestation in adulthood. Arch Clin Neuropsychol. 2005;20:249–269.
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36:21–29.
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995;152:1652–1658.
   PubMed Web of Science ®Google Scholar
• Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112:497–507.
   PubMed Web of Science ®Google Scholar
• Arias AJ, Gelertner J, Chan G, Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008;33:1199–1207.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997;185:475–482.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT, Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005;162:1621–1627.
   PubMed Web of Science ®Google Scholar
• King VL, Brooner RK, Kidorf MS, Stoller KB, Mirsky AF. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis. 1999;187:487–495.
   PubMed Web of Science ®Google Scholar
• Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs. 2005;19:643–655.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7:156–163.
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T, Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112–120.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adler LA, Weiss MD, Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96:145–154.
   PubMed Web of Science ®Google Scholar
• Heil SH, Holmes HW, Bickel WK, Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 2002;67:149–156.
   PubMed Web of Science ®Google Scholar
• Ring BJ, Gillespie JS, Eckstein JA, Wrighton SA. Identification of the human cytochromes P450 responsible for atomoxetine metabolism. Drug Metab Dispos. 2002;30:319–323.
   PubMed Web of Science ®Google Scholar
• Carlson A, Lindqvist M. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J Pharm Pharmac. 1973;25:377–440.
   Google Scholar
• Corrodi H, Fuxe K, Hökfelt T. The effect of ethanol on the activity of central catecholamine neurons in the rat brain. J Pharm Pharmac. 1966;18:821–823.
   PubMed Web of Science ®Google Scholar
• Rossetti ZL, Longu G, Mercuro G, Hmaidan Y, Gessa GL. Biphasic effect of ethanol on noradrenaline release in the frontal cortex of awake rats. Alcohol Alcohol. 1992;27:477–480.
   Google Scholar
• Aston-Jones G, Foote SL, Bloom FE. Low doses of ethanol disrupt sensory responses of brain noradrenergic neurons. Nature. 1982;296:857–860.
   Google Scholar
• Verbanck P, Seutin V, Dresse A, Electrophysiological effects of ethanol on monoaminergic neurons: an in vivo and in vitro study. Alcohol Clin Exp Res. 1990;14:728–735.
   Google Scholar
• Banerjee SP, Sharma VK, Khanna JM. Alterations in beta-adrenergic receptor binding during ethanol withdrawal. Nature. 1978;276:407–409.
   PubMed Web of Science ®Google Scholar
• Arango V, Underwood MD, Mann JJ. Fewer pigmented neurons in the locus coeruleus of uncomplicated alcoholics. Brain Res. 1994;650:1–8.
   Google Scholar
• Adler LA, Spencer TJ, Levine LR, Functional outcomes in the treatment of adults with ADHD. J Atten Disord. 2008;11:720–727.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Adler L, Cohen J. Diagnosis and evaluation of adults with ADHD. In: Spencer T, ed. Psychiatric Clinics of North America. Philadelphia, PA: Saunders Press; 2004:187–201.
   Google Scholar
• Sobel LC, Sobel MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen JP, eds. Measuring alcohol consumption: Psychosocial and biochemical methods. Totowa, NH: Humana Press; 2006:41–72.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV TR axis I disorders, research edition, patient version SCID I/P. New York: Biometrics Research, New York State Psychiatric Institute; 2002.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–296.
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Watts S, Ohashi Y, Bridging data between two ethnic populations. A new application of matched case-control methodology. Drug Info J. 2002;36:349–356.
   Google Scholar
• World Medical Association. Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects. As adopted by the 18th General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd General Assembly, Edinburgh, Scotland, October 2000.
   Google Scholar
• Guy W. ECDEU Assessment manual for psychopharmacology, revised. Publication ADM 76–338. Bethesda, MD: United States Department of Health, Education, and Welfare; 1976:218–222.
   Google Scholar
• Conners CK. Conners' Rating Scales: Revised technical manual. North Tonawanda, NY: Multi-Health Systems, Inc.; 1997.
   Google Scholar
• Lindros KO, Stowell L, Väänänen H, Uninterrupted prolonged ethanol oxidation as a main pathogenetic factor of alcoholic liver damage: evidence from a new liquid diet animal model. Liver. 1983;3:79–91.
   Google Scholar
• STRATTERA, (atomoxetine HCl) [package insert]. Indianapolis, IN: Eli Lilly and Company; 2008.
   Google Scholar
• Bangs ME, Jin L, Zhang S, Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. Drug Saf. 2008;31:345–354.
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1988;52:15–25.
   Google Scholar
• Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis. 2002;21:1–16.
   PubMed Web of Science ®Google Scholar
• Upadhyaya HP, Brady KT, Sethuraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001;21:116–118.
   PubMed Web of Science ®Google Scholar
• Schubiner H, Saules KK, Arfken CL, Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002;10:286–294.
   PubMed Web of Science ®Google Scholar
• Wilens T, Prince J, Murphy K, Bupropion SR treatment study in adults with ADHD and substance abuse: preliminary findings. Scientific Proceedings of the 48th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, HI, October 23–28, 2001, pp. 151–152. [Abs Nr P40].
   Google Scholar